Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty

Study Group, CRISTAL; S. Sidhu, Verinder; Kelly, Thu-Lan; Pratt, Nicole; E. Graves, Stephen; Buchbinder, Rachelle; Adie, Sam; Cashman, Kara; Ackerman, Ilana; Bastiras, Durga; Brighton, Roger; W. R. Burns, Alexander; Hock Chong, Beng; Clavisi, Ornella; Cripps, Maggie; Dekkers, Mark; de Steiger, Richard; Dixon, Michael; Ellis, Andrew; C. Griffith, Elizabeth; Hale, David; Hansen, Amber; Harris, Anthony; Hau, Raphael; Horsley, Mark; James, Dugal; Khorshid, Omar; Kuo, Leonard; Lewis, Peter; Lieu, David; Lorimer, Michelle; MacDessi, Samuel; McCombe, Peter; McDougall, Catherine; Mulford, Jonathan; Maree Naylor, Justine; S. Page, Richard; Radovanovic, John; Solomon, Michael; Sorial, Rami; Summersell, Peter; Tran, Phong; L. Walter, William; Webb, Steve; Wilson, Chris; Wysocki, David; A. Harris, Ian

doi:10.1001/jama.2022.13416

Public

Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty

Published in JAMA • Aug 23, 2022

NobleIDark:/48914/w1/20260526/A09711D1Record on NobleID

Authors:

CRISTAL Study Group

,

Verinder S. Sidhu

,

Thu-Lan Kelly

Abstract

Importance There remains a lack of randomized trials investigating aspirin monotherapy for symptomatic venous thromboembolism (VTE) prophylaxis following total hip arthroplasty (THA) or total knee arthroplasty (TKA). Objective To determine whether aspirin was noninferior to enoxaparin in preventing ...

Discussions